Quinolinic acid and other kynurenines in the central nervous system.
Stone
T W
TW
Connick
J H
JH
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D003292:Convulsants; D005971:Glutamates / Q000494:pharmacology; D018698:Glutamic Acid; D006624:Hippocampus / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007737:Kynurenine / Q000378:metabolism*; D018377:Neurotransmitter Agents; D010875:Pipecolic Acids / Q000633:toxicity; D017378:Quinolinic Acid; D011805:Quinolinic Acids / Q000032:analysis / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D012160:Retina / Q000187:drug effects; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D014366:Tryptophan Oxygenase / Q000378:metabolism
D003292:Convulsants; D005971:Glutamates; D018377:Neurotransmitter Agents; D010875:Pipecolic Acids; D011805:Quinolinic Acids; D007737:Kynurenine; D018698:Glutamic Acid; C029262:2,3-piperidinedicarboxylic acid; D014366:Tryptophan Oxygenase; D017378:Quinolinic Acid